Table 3.
Rates of adjuvant treatment in the sentinel lymph node biopsy and completion axillary lymph node dissection groups
| Adjuvant treatment | Group; no. (%) | p value | |
|---|---|---|---|
| SLNB, n = 95 | CALND, n = 90 | ||
| Radiation | 0.15 | ||
| None | 19 (20.0) | 14 (15.6) | |
| Breast/chest wall | 17 (17.9) | 27 (30.0) | |
| Breast/chest wall and axilla | 59 (62.1) | 49 (54.4) | |
| Systemic chemotherapy | 44 (46.3) | 68 (75.6) | < 0.001 |
| Intervening chemotherapy between SLNB and CALND | 9 (10) | ||
| Hormonal therapy | 85 (89.5) | 79 (87.8) | 0.72 |
CALND = axillary lymph node dissection; NA = not applicable; SLNB = sentinel lymph node biopsy.